LogicBio Therapeutics, Inc.

DB:0IF 주식 보고서

시가총액: €68.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

LogicBio Therapeutics 관리

관리 기준 확인 1/4

주요 정보

Fred Chereau

최고 경영자

US$2.2m

총 보상

CEO 급여 비율24.3%
CEO 임기6.6yrs
CEO 소유권n/a
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간3.4yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Fred Chereau 의 보수는 LogicBio Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021US$2mUS$543k

-US$40m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$36m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$2mUS$479k

-US$33m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$40m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$633kUS$510k

-US$40m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$29m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$2mUS$411k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$779kUS$385k

-US$8m

보상 대 시장: Fred's total compensation ($USD2.23M) is above average for companies of similar size in the German market ($USD433.84K).

보상과 수익: Fred's compensation has increased whilst the company is unprofitable.


CEO

Fred Chereau (55 yo)

6.6yrs

테뉴어

US$2,228,208

보상

Mr. Frederic Chereau, M.B.A., also known as Fred, is the Chairman of the Board of Coave Therapeutics since October 2022 and has been its Independent Non-Executive Director since October 2021. He has execut...


리더십 팀

이름위치테뉴어보상소유권
Frederic Chereau
President6.6yrsUS$2.23m데이터 없음
Mark Kay
Co-Founderno dataUS$156.64k0%
$ 0
Daniel Gruskin
Chief Medical Officer2.4yrsUS$1.54m0%
$ 0
Leszek Lisowski
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Adi Barzel
Co-Founder8.3yrs데이터 없음데이터 없음
Joshua Blacher
Interim CFOless than a year데이터 없음데이터 없음
Matthias Hebben
Global VP & Head of Technology Development3.6yrs데이터 없음데이터 없음
Mariana Nacht
Chief Scientific Officer2yrsUS$1.34m데이터 없음
Andrea Paul
General Counsel & Corporate Secretary1.5yrs데이터 없음데이터 없음
Grace Lochhead
VP & Head of Human Resources1.2yrs데이터 없음데이터 없음
Janice Olson
Senior Vice President of Strategy & Portfolio Management1.4yrs데이터 없음데이터 없음
Michael Franken
Chief Business Officer1.3yrs데이터 없음데이터 없음

1.8yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: 0IF's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


이사회 구성원

이름위치테뉴어보상소유권
Frederic Chereau
Presidentno dataUS$2.23m데이터 없음
Mark Kay
Co-Founder6.8yrsUS$156.64k0%
$ 0
Leszek Lisowski
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Michael Wyzga
Independent Director4.2yrsUS$87.39k0%
$ 0
Richard Moscicki
Independent Chairman of the Board4.1yrsUS$113.64k0%
$ 0
Mark Enyedy
Independent Director2.7yrsUS$82.02k0%
$ 0
Markus Grompe
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Leon Chen
Independent Director6.8yrsUS$81.14k0%
$ 0
J. Goater
Independent Director1.9yrsUS$76.77k0%
$ 0
Daphne Karydas
Independent Director1.9yrsUS$79.64k0%
$ 0
David Russell
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Susan Kahn
Independent Directorless than a yearUS$40.31k데이터 없음

3.4yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 이사회: 0IF's board of directors are considered experienced (3.4 years average tenure).